Diamond Equity Research Initiates Coverage on Genprex Inc. (NASDAQ: GNPX) with a Valuation of $13 Per Share
02 juil. 2018 09h30 HE
|
Genprex Inc Registered Shs
NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies has...
Exosome Diagnostics Announces Publication of a Highly Sensitive Exosome Based Liquid Biopsy Test for EGFR T790M Mutations in Plasma from Non-Small Cell Lung Cancer Patients
20 mars 2018 07h46 HE
|
Exosome Diagnostics
Waltham, MA, March 20, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., a developer of revolutionary, biofluid-based molecular diagnostics, recently published a study on the detection of the...
Napoli Shkolnik Files Two Cancer Cases for Railroad Workers in Texas
21 févr. 2018 17h29 HE
|
Napoli Shkolnik PLLC
AUSTIN, TX--(Marketwired - February 21, 2018) - Napoli Shkolnik has filed two cases in Fort Worth, Texas against BNSF Railway, for injuries that two former employees suffered related to toxic...
Precipio Launches Unique Lung Cancer Monitoring Test for Therapy Resistance
15 févr. 2018 08h38 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO) announced today its launch of the first lung cancer treatment resistance panel specifically for the critical...
Leading Medical Organizations Update Guideline for Molecular Testing and Targeted Therapies in Lung Cancer
23 janv. 2018 14h15 HE
|
IASLC
DENVER, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Rapid advancements in the molecular diagnostic testing of lung cancer have led to new treatments and greater hope for patients battling lung cancer, the...
Dr. Brian O’Connor Joins Veritas Pharma Advisory Board
02 janv. 2018 03h05 HE
|
Veritas Pharma Inc.
VANCOUVER, British Columbia, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor,...
Exosome Diagnostics Publishes a Study Demonstrating Superior Performance of ExoLution™ Plus Liquid Biopsy Platform in Lung Cancer
19 déc. 2017 07h51 HE
|
Exosome Diagnostics
Waltham, MA, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc., recently published a study in the Journal Annals of Oncology, of EGFR Liquid Biopsy detection in patients with Non-Small...
Discovery of Innate Immune Mechanisms of a Novel Microbial-based Approach for the Treatment of Lung Cancer
28 nov. 2017 12h43 HE
|
Qu Biologics
VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc. (Qu), a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of...
Global Lung Cancer Awareness Month Coalition Kicks-Off 2017 Awareness Month
06 nov. 2017 15h13 HE
|
Lung Cancer Awareness Month Coalition
WASHINGTON, Nov. 06, 2017 (GLOBE NEWSWIRE) -- The Lung Cancer Awareness Month Coalition (LCAMC), a group of more than twenty research and advocacy organizations from around the world focused on...
New Study Reports Favorable Results for Intuitive Surgical’s Flexible Robotics Platform
02 nov. 2017 09h00 HE
|
Intuitive Surgical, Inc.
SUNNYVALE, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) -- Results from the first clinical study evaluating a new flexible robotics platform under development by Intuitive Surgical were presented at the...